NASDAQ: CABACabaletta Bio Inc Stock Ownership - Who owns Cabaletta Bio?
Insider buying vs selling
Have Cabaletta Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gwendolyn Binder | President Science Tech. | 2026-01-21 | 11,312 | $2.19 | $24.76kBuy |
| Catherine Bollard | Director | 2026-01-21 | 4,405 | $2.27 | $9.98kBuy |
| David J. Chang | Chief Medical Officer | 2026-01-21 | 8,800 | $2.26 | $19.89kBuy |
| Steve Gavel | Chief Commercial Officer | 2026-01-21 | 22,170 | $2.27 | $50.22kBuy |
| Michael Gerard | General Counsel | 2026-01-21 | 6,600 | $2.27 | $14.98kBuy |
| Steven Nichtberger | President CEO | 2026-01-21 | 45,000 | $2.24 | $100.80kBuy |
| Mark Simon | Director | 2026-01-21 | 11,061 | $2.28 | $25.26kBuy |
| Shawn Tomasello | Director | 2026-01-21 | 22,725 | $2.21 | $50.31kBuy |
CABA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CABA insiders and whales buy or sell their stock.
CABA Shareholders
What type of owners hold Cabaletta Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jennison Associates LLC | 9.25% | 8,905,699 | $24.94M | Institution |
| Vanguard Group Inc | 4.59% | 4,419,458 | $12.37M | Institution |
| Blackrock Inc | 2.42% | 2,328,470 | $6.52M | Institution |
| James E. Flynn | 1.69% | 1,628,506 | $4.56M | Insider |
| Renaissance Technologies LLC | 1.58% | 1,522,583 | $4.26M | Institution |
| Steven Nichtberger | 1.45% | 1,394,483 | $3.90M | Insider |
| Morgan Stanley | 1.40% | 1,343,708 | $3.76M | Institution |
| Geode Capital Management LLC | 1.13% | 1,085,816 | $3.04M | Institution |
| Marshall Wace LLP | 1.00% | 959,076 | $2.69M | Institution |
| Schroder Investment Management Group | 0.79% | 756,637 | $2.12M | Institution |
CABA vs Biotech Stocks
Cabaletta Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.